General Research Funding - CMT Research Foundation
Forecasted
General Research Funding - CMT Research Foundation supports researchers and clinicians pursuing therapeutics for all types of Charcot-Marie-Tooth disease to accelerate treatments and cures.
Browse similar grants
Funder: CMT Research Foundation
Due Dates: Submission deadlines not announced (Full proposals accepted quarterly; confirm current availability)
Funding Amounts: Typically $100,000–$200,000 per year for one to three years; higher budgets considered
Summary: Supports research leading to therapeutics for all types of Charcot-Marie-Tooth disease, with the goal of delivering treatments and cures.
Key Information: Funding requires potential for a return on investment if resulting intellectual property becomes commercially profitable.
Description
The CMT Research Foundation (CMTRF) funds promising research leading to therapeutics for all types of Charcot-Marie-Tooth disease (CMT). The patient-led foundation focuses primarily on translational research, while also supporting discovery-stage work with a clear link to accelerating treatments and cures. It prioritizes projects with the highest likelihood of leading to clinical trials and approved treatments in the near term.
Funding decisions are guided by CMTRF’s research priorities: advancing gene therapy, promoting nerve health, overcoming delivery challenges, and de-risking clinical trials. Researchers with other promising approaches are encouraged to contact the foundation. CMT and industry advisors participate in an iterative funding process, with scientific review by the Scientific Advisory Board. CMTRF also encourages collaborations and co-funding that can help advance findings toward therapeutic development.
